US FDA Grants Investigational Device Exemption (IDE)  to EndoQuest™ Robotics for Its Flexible Robotic System
US FDA Grants Investigational Device Exemption (IDE) to EndoQuest™ Robotics for Its Flexible Robotic System
10 déc. 2024 11h30 HE | EndoQuest Robotics
Houston, TX, Dec. 10, 2024 (GLOBE NEWSWIRE) -- The US Food and Drug Administration (FDA) has granted EndoQuest Robotics, Inc., a privately-held pioneer in the development of flexible endoluminal...